These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 24055980)

  • 1. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Mao P; Manczak M; Shirendeb UP; Reddy PH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoquinone alleviates vincristine-induced neuropathic pain through inhibiting oxidative stress and apoptosis via the improvement of mitochondrial dysfunction.
    Chen XJ; Wang L; Song XY
    Biomed Pharmacother; 2020 May; 125():110003. PubMed ID: 32187955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
    Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
    Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
    Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
    Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
    Dashdorj A; Jyothi KR; Lim S; Jo A; Nguyen MN; Ha J; Yoon KS; Kim HJ; Park JH; Murphy MP; Kim SS
    BMC Med; 2013 Aug; 11():178. PubMed ID: 23915129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoquinone ameliorates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice.
    Yang D; Xu D; Wang T; Yuan Z; Liu L; Shen Y; Wen F
    Int Immunopharmacol; 2021 Jan; 90():107149. PubMed ID: 33191175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis.
    Miquel E; Cassina A; Martínez-Palma L; Souza JM; Bolatto C; Rodríguez-Bottero S; Logan A; Smith RA; Murphy MP; Barbeito L; Radi R; Cassina P
    Free Radic Biol Med; 2014 May; 70():204-13. PubMed ID: 24582549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
    Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
    Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.
    Gioscia-Ryan RA; LaRocca TJ; Sindler AL; Zigler MC; Murphy MP; Seals DR
    J Physiol; 2014 Jun; 592(12):2549-61. PubMed ID: 24665093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.
    Lowes DA; Thottakam BM; Webster NR; Murphy MP; Galley HF
    Free Radic Biol Med; 2008 Dec; 45(11):1559-65. PubMed ID: 18845241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.
    Young ML; Franklin JL
    Mol Cell Neurosci; 2019 Dec; 101():103409. PubMed ID: 31521745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol.
    Feillet-Coudray C; Fouret G; Ebabe Elle R; Rieusset J; Bonafos B; Chabi B; Crouzier D; Zarkovic K; Zarkovic N; Ramos J; Badia E; Murphy MP; Cristol JP; Coudray C
    Free Radic Res; 2014 Oct; 48(10):1232-46. PubMed ID: 25066801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.
    Ng LF; Gruber J; Cheah IK; Goo CK; Cheong WF; Shui G; Sit KP; Wenk MR; Halliwell B
    Free Radic Biol Med; 2014 Jun; 71():390-401. PubMed ID: 24637264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion
    Gan L; Wang Z; Si J; Zhou R; Sun C; Liu Y; Ye Y; Zhang Y; Liu Z; Zhang H
    Toxicol Appl Pharmacol; 2018 Feb; 341():1-7. PubMed ID: 29317239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ.
    Stucki DM; Ruegsegger C; Steiner S; Radecke J; Murphy MP; Zuber B; Saxena S
    Free Radic Biol Med; 2016 Aug; 97():427-440. PubMed ID: 27394174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis.
    Liu Y; Zhu B; Wang X; Luo L; Li P; Paty DW; Cynader MS
    J Neuroimmunol; 2003 Jun; 139(1-2):27-35. PubMed ID: 12799017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.
    Rodriguez-Cuenca S; Cochemé HM; Logan A; Abakumova I; Prime TA; Rose C; Vidal-Puig A; Smith AC; Rubinsztein DC; Fearnley IM; Jones BA; Pope S; Heales SJ; Lam BY; Neogi SG; McFarlane I; James AM; Smith RA; Murphy MP
    Free Radic Biol Med; 2010 Jan; 48(1):161-72. PubMed ID: 19854266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
    Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
    Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α.
    Xi Y; Feng D; Tao K; Wang R; Shi Y; Qin H; Murphy MP; Yang Q; Zhao G
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2859-2870. PubMed ID: 29842922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.